|
| 36413125 | A randomized, open-label, two-treatment crossover study to evaluate the effect of food on the pharmacokinetics of diazepam nasal spray in healthy adults. | Epilepsia | 2023 |
| 36919379 | Tolerability and pharmacokinetics of intravenous allopregnanolone with and without midazolam pretreatment in two healthy dogs. | Epilepsia Open | 2023 |
| 34862270 | Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs. | J Pharmacol Exp Ther | 2022 |
| 33405197 | Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery. | Neurotherapeutics | 2021 |
| 33914090 | Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam. | Arch Toxicol | 2021 |
| 34478772 | Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus. | Neurotoxicology | 2021 |
| 34008857 | Cortical excitability threshold can be increased by the AMPA blocker Perampanel in amyotrophic lateral sclerosis. | Muscle Nerve | 2021 |
| 30905768 | Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication. | Neurobiol Dis | 2020 |
| 31965829 | Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. | Epilepsy Curr | 2020 |
| 33344752 | Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial. | Alzheimers Dement (N Y) | 2020 |
| 32915470 | Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate-induced status epilepticus in rats. | Ann N Y Acad Sci | 2020 |
| 32120063 | Mechanisms of action of currently used antiseizure drugs. | Neuropharmacology | 2020 |
| 32303805 | The chemical convulsant diisopropylfluorophosphate (DFP) causes persistent neuropathology in adult male rats independent of seizure activity. | Arch Toxicol | 2020 |
| 31526646 | Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam. | Epilepsy Behav | 2020 |
| 30187385 | Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study. | Mol Neurobiol | 2019 |
| 31699662 | Diazepam buccal film for the treatment of acute seizures. | Epilepsy Behav | 2019 |
| 31801886 | Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunction. | Sci Transl Med | 2019 |
| 28927958 | Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndrome. | Neurobiol Dis | 2018 |
| 29682729 | Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats. | Epilepsia | 2018 |
| 29453777 | Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus. | Epilepsia | 2018 |
| 29247482 | Commonalities in epileptogenic processes from different acute brain insults: Do they translate? | Epilepsia | 2018 |
| 27986596 | Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an Angelman syndrome mouse model. | Neuropharmacology | 2017 |
| 28416442 | Allopregnanolone decreases interictal spiking and fast ripples in an animal model of mesial temporal lobe epilepsy. | Neuropharmacology | 2017 |
| 28485718 | Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. | Sci Data | 2017 |
| 28428226 | Rapid Throughput Analysis of GABA<sub>A</sub> Receptor Subtype Modulators and Blockers Using DiSBAC<sub>1</sub>(3) Membrane Potential Red Dye. | Mol Pharmacol | 2017 |
| 28707277 | Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. | Neurotherapeutics | 2017 |
| 28589168 | First-in-man allopregnanolone use in super-refractory status epilepticus. | Ann Clin Transl Neurol | 2017 |
| 26801895 | Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. | Cold Spring Harb Perspect Med | 2016 |
| 26525567 | Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. | Psychopharmacology (Berl) | 2016 |
| 27768878 | A New SV2A Ligand for Epilepsy. | Cell | 2016 |
| 27330452 | 2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. | Epilepsy Curr | 2016 |
| 27467073 | Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents. | Ann N Y Acad Sci | 2016 |
| 26912516 | A fatty acid in the MCT ketogenic diet for epilepsy treatment blocks AMPA receptors. | Brain | 2016 |
| 25256961 | The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant. | Neurotherapeutics | 2015 |
| 26378885 | Contrasting actions of a convulsant barbiturate and its anticonvulsant enantiomer on the α1 β3 γ2L GABAA receptor account for their in vivo effects. | J Physiol | 2015 |
| 26581972 | Is a separate monotherapy indication warranted for antiepileptic drugs? | Lancet Neurol | 2015 |
| 26039057 | Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease. | PLoS One | 2015 |
| 25882826 | Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures. | Neuropharmacology | 2015 |
| 25616473 | Current understanding of the mechanism of action of the antiepileptic drug lacosamide. | Epilepsy Res | 2015 |
| 24671870 | The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. | Neurotherapeutics | 2014 |
| 25448683 | Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication. | Toxicol Appl Pharmacol | 2014 |
| 25229608 | Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons. | PLoS One | 2014 |
| 25363147 | Pediatric super-refractory status epilepticus treated with allopregnanolone. | Ann Neurol | 2014 |
| 24760837 | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | J Neurosci | 2014 |
| 24705905 | Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural forms. | Psychopharmacology (Berl) | 2014 |
| 23298414 | Glia and epilepsy: excitability and inflammation. | Trends Neurosci | 2013 |
| 24349022 | Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures. | PLoS One | 2013 |
| 23909851 | Issues related to development of new antiseizure treatments. | Epilepsia | 2013 |
| 23909850 | Epilepsy therapy development: technical and methodologic issues in studies with animal models. | Epilepsia | 2013 |
| 23906638 | Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat. | Neuroscience | 2013 |